Watch this live interview on CNBC Squawk Box Asia where our CEO, Simranjit Singh talks about Guardant Health AMEA’s growth strategy for the next two years and the advantages of using liquid biopsies such as the FDA-approved Guardant360 test for advanced cancer patients.

Interview footage on CNBC’s website: https://lnkd.in/e5QpCPw

Visit us online @ guardanthealthamea.com to find out more about Guardant360®, the global leader in liquid biopsy. If you have any queries, send us an email at clientservices@guardantamea.com or contact us on WhatsApp: +65 8940 0360.

Guardant360®. Test. Take Action.